Filing Details
- Accession Number:
- 0001645627-18-000021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-17 15:30:49
- Reporting Period:
- 2018-04-12
- Accepted Time:
- 2018-04-17 15:30:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-04-12 | 1,000 | $0.04 | 24,945,789 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-04-12 | 1,000 | $0.04 | 24,946,789 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-04-13 | 1,000 | $0.04 | 24,947,789 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-04-13 | 1,000 | $0.04 | 24,948,789 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-04-16 | 1,000 | $0.03 | 24,949,789 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-04-16 | 2,000 | $0.03 | 24,951,789 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-04-16 | 1,000 | $0.03 | 24,952,789 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-04-16 | 1,000 | $0.04 | 24,953,789 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-04-16 | 1,000 | $0.03 | 24,954,789 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |